(thirdQuint)Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions.

 This was an open-label, randomized, single-dose, 2-way crossover, relative bioavailability study performed on 40 healthy adult male subjects.

 As per protocol, enough healthy, adult, human subjects were to be enrolled in the study to allow the dosing of 40 subjects in the first period.

 40 subjects were enrolled and a total of 37 subjects completed both the periods of study.

.

 Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions@highlight

The study was conducted as an open label, balanced, randomised, two-treatment, two-period, two-sequence, single-dose crossover bioavailability study on fenofibrate formulations comparing fenofibrate 160 mg tablets of Ranbaxy Laboratories with Tricor 160 mg tablets in healthy, adult, human subjects under fasting conditions.

